Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Malignant Ascites × Paracentesis × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 2 Ovarian High Grade Serous Adenocarcinoma 1 Malignant Ascites 1

Interventions

Bevacizumab 2 regramostim 1 recombinant human tumor necrosis factor-binding protein-1 1 pembrolizumab 1 molgramostim 1 irinotecan sucrosofate 1 Paracentesis 1 Nivolumab 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06432296 2025-07-20

Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody

Wuhan YZY Biopharma Co., Ltd.

Phase 3 Active not recruiting

Malignant Ascites

Data powered by HemOnc (CC BY 4.0) Colophon ⚡